An Overview of Systematic Reviews of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 83 citations in OpenAlex.

1. Clinical trial characteristics and intervention profiles for mild cognitive impairment: a systematic analysis of WHO ICTRP registry.Frontiers in pharmacology · 2026
   Pooled it
2. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.Advances in nutrition (Bethesda, Md.) · 2025
   Pooled it
3. Oxidative medicine and cellular longevity · 2021
   Pooled it
4. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis.Frontiers in physiology · 2019
   Pooled it
5. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress.Scientific reports · 2023
   Trial
6. Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B.Medicine · 2018
   Trial
7. Health Benefits of a StandardizedFood science & nutrition · 2026
   Article
8. Frontiers in nutrition · 2026
   Article
9. Editorial: The role of neurogenesis in cognitive decline during aging.Frontiers in genetics · 2026
   Article
10. Treatment of Shengqingtongqiao Decoction for mild cognitive impairment of white matter lesions study protocol for a randomized, double-blind, double-dummy, parallel controlled trial.BMC complementary medicine and therapies · 2024
    Article
11. Alzheimer's Disease: Cellular and Pharmacological Aspects.Geriatrics (Basel, Switzerland) · 2024
    Review
12. A review of the WHO strategy on traditional, complementary, and integrative medicine from the perspective of academic consortia for integrative medicine and health.Frontiers in medicine · 2024
    Review
13. Effectiveness of neurobic exercise program on memory performance in community-dwelling older adults with mild cognitive impairment: A randomized controlled crossover trial.Belitung nursing journal · 2023
    Article
14. Efficacy of a mixture of Ginkgo biloba, sesame, and turmeric on cognitive function in healthy adults: Study protocol for a randomized, double-blind, placebo-controlled trial.PloS one · 2023
    Article
15. A pilot randomized controlled trial of WeiNaoKang (SaiLuoTong) in treating vascular dementia.Aging medicine (Milton (N.S.W)) · 2022
    Article
16. Antioxidants (Basel, Switzerland) · 2022
    Review
17. Discrimination of Adulterated Ginkgo Biloba Products Based on 2T2D Correlation Spectroscopy in UV-Vis Range.Molecules (Basel, Switzerland) · 2022
    Article
18. Frontiers in pharmacology · 2022
    Review
19. Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia.Nutrients · 2021
    Review
20. Mild Cognitive Impairment and Mild Dementia: The Role ofPharmaceuticals (Basel, Switzerland) · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as